The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs to determine the Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile
Principal investigator: Katriina Peltola
Trial site: HUS Comprehensive Cancer Center
